Clinical Trials for healthy young volunteers
Phase 1 Clinical Trials
On the 12th February 2009 Richmond Pharmacology became the first CRO in Europe to gain ethics approval to conduct a Phase I healthy volunteer trial in healthy young females aged 14-17.
Richmond Pharmacology is a clinical research specialist
This landmark decision by Great Ormond Street Ethics Committee to allow this study to be conducted paves the way for future studies of this age group.
The first subjects were dosed into this study on the 28th February 2009, just 16 days after gaining ethics approval, an achievement in itself.
The study being conducted by Richmond Pharmacology aims to determine the effect a study drug, (a new oral contraceptive pill), has on the body and if there is a difference in what happens to the drug in females aged 18-50 compared to females aged 14-17.
The study itself is typical of many Phase I trials of these compounds, however it is the population being included that makes this a pivotal study.
For many years the United Kingdom has been known for the conduct of good quality clinical studies across all phases. Recently some of these trials have been conducted outside of the UK However the approval of this study marks a substantial shift in thinking and attitude towards clinical trial conduct in the UK and Richmond Pharmacology are proud to be at the centre of this pioneering move to once again make the UK THE place to conduct more specialised clinical research
In addition to providing high quality full service clinical studies, Richmond Pharmacology now has the proven ability to conduct a wide variety of studies complicated in their design and population required.
Richmond Pharmacology’s founding Directors are still at the heart of the company. Their hands on approach coupled with a dedicated and highly skilled staff ensure we are able to meet the challenges set by sponsors.
Mail this post